The non-case of AstraZeneca

Not only medicine but its communication should always be evidence-based. It requires centralizing and evaluating all big data concerning the treated population in order to avoid simplistic conclusions. No indication of any available data justifies the pharmaceutical quagmire in which the Anglo-Swedish giant has fallen.